Supply of POM-V/POM-VPS medicines in the presence of a veterinary surgeon

• A clinical assessment must have been carried out.
• Animals must be under the care of a veterinary surgeon.
• The veterinary surgeon must advise on safe administration, warnings for use and contraindications.
• Only the minimum amount required for treatment should be supplied.
• The veterinary surgeon must ensure that the user intends to use the medicine for an authorized use and is competent to use it safely.
• The veterinary surgeon must supply from practice premises registered with the Royal College of Veterinary Surgeons (RCVS).

Supply of POM-V/POM-VPS medicines in the absence of a veterinary surgeon

• Each individual transaction must be authorized by a veterinary surgeon.
• The veterinary surgeon must be satisfied (via a suitably qualified person (SQP) or otherwise) that the person handing over the medicine to the client is competent to do so.
• Only the minimum amount required for treatment should be supplied.
• The veterinary surgeon must ensure that the user intends to use the medicine for an authorized use and is competent to use it safely.

Supply of POM-VPS/NFA-VPS medicines by a suitably qualified person

• The SQP must personally supply the medicines, or be in a position to intervene when the medicines are handed over, or check the medicines before despatch.
• The same requirements to advise on safe administration, warnings and contraindications, to ensure that the user is competent and to supply the minimum amount required for treatment apply (as for veterinary surgeons).
• There should be no supply of medicines for use outside their marketing authorizations.
• SQPs may break open any packaging other than the immediate packaging of a veterinary medicinal product (VMP).
• The SQP must supply either from premises approved by the Secretary of State, a registered pharmacy or a RCVS registered practice premises.

Supply of AVM-GSL medicines
AVM-GSL medicines can be supplied by any retailer to any purchaser without restriction.

General information
Where possible all VMPs should be supplied in their authorized packaging. If a VMP is supplied in a container other than that specified in the marketing authorization, the person supplying the VMP should ensure that the container is suitably labelled and must supply sufficient written information (which may include a copy of the summary of product characteristics or the package leaflet) to enable the medicine to be used safely.

No out-of-date medicines may be supplied.

Suitably qualified person
Prescribing and labelling